Pablo Avilés
Impact in
- Biotechnology top 5%
- Marine Sponges and Natural Products
- Cancer Research top 10%
- Synthesis and Biological Activity
Papers in
- Oncology 25
- Cancer Treatment and Pharmacology 9
- HER2/EGFR in Cancer Research 5
- Lung Cancer Research Studies 5
-
- Cancer therapeutics and mechanisms 11
- Co-authors
- Carlos M. Galmarini (18 shared papers)Juan Fernando Martínez-Leal (7 shared papers)Carmen Cuevas (27 shared papers)María José Guillén (27 shared papers)Emmanuel Compe (1 shared paper)Jean‐Marc Egly (1 shared paper)Gema Santamaría Núñez (2 shared papers)Carlos Mario Genes Robles (1 shared paper)
- Journals
- Cancer Research (14 papers)Biochemical Pharmacology (4 papers)Molecular Cancer Therapeutics (4 papers)Journal of Pharmaceutical and Biomedical Analysis (4 papers)Rapid Communications in Mass Spectrometry (3 papers)
- Partner nations
- SpainBelgiumUnited States
In The Last Decade
Pablo Avilés
67 papers receiving 916 citations
Peers
Comparison fields: 5 of 96
- Biotechnology 129
- Cancer Research 153
- Oncology 252
- Toxicology 26
- Pharmacology 124
Countries citing papers authored by Pablo Avilés
This map shows the geographic impact of Pablo Avilés's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Avilés with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Avilés more than expected).
Fields of papers citing papers by Pablo Avilés
This network shows the impact of papers produced by Pablo Avilés. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Avilés. The network helps show where Pablo Avilés may publish in the future.
Co-authors
The 25 scholars most cited alongside Pablo Avilés, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 118 | |
| 2 | 2008 | 76 | |
| 3 | 2016 | 70 | |
| 4 | 2009 | 62 | |
| 5 | 2014 | 50 | |
| 6 | 1995 | 44 | |
| 7 | 2013 | 34 | |
| 8 | 2019 | 29 | |
| 9 | 2015 | 28 | |
| 10 | 2016 | 27 | |
| 11 | 2018 | 27 | |
| 12 | 2020 | 22 | |
| 13 | 2021 | 20 | |
| 14 | 2013 | 20 | |
| 15 | 2009 | 20 | |
| 16 | 2022 | 18 | |
| 17 | 2018 | 17 | |
| 18 | 2017 | 17 | |
| 19 | 2011 | 15 | |
| 20 | 2020 | 14 |
About Pablo Avilés
Pablo Avilés is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Organic Chemistry, having authored 73 papers that have together received 939 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (11 papers), Synthesis and Biological Activity (9 papers), Cancer Treatment and Pharmacology (9 papers), Radiation Detection and Scintillator Technologies (5 papers), Radiation Effects in Electronics (5 papers), HER2/EGFR in Cancer Research (5 papers), Lung Cancer Research Studies (5 papers) and Microtubule and mitosis dynamics (4 papers). The work is most often cited by research in Biotechnology (129 citations), Cancer Research (153 citations), Oncology (252 citations), Toxicology (26 citations) and Pharmacology (124 citations). Pablo Avilés has collaborated with scholars based in Spain, Belgium and United States. Frequent co-authors include Carlos M. Galmarini, Juan Fernando Martínez-Leal, Carmen Cuevas, María José Guillén, Emmanuel Compe, Jean‐Marc Egly, Gema Santamaría Núñez, Carlos Mario Genes Robles, Frédéric Coin and Pilar Calvo. Their work appears in journals such as Cancer Research, Biochemical Pharmacology, Molecular Cancer Therapeutics, Journal of Pharmaceutical and Biomedical Analysis and Rapid Communications in Mass Spectrometry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.